OHLCX Market Research
Delayed

ABBV

ABBV, or AbbVie Inc., is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex diseases.

+2.66 (+0.94%) Nov 20, 2026 19:42 ET Delayed
Open
284.20
High
290.23
Low
284.00
Prev close
283.54
Volume
8M
Avg vol 10
5M

Today · Market closed · opens Mon 9:30 AM

Price

ABBV chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 286.20

Strong sellNeutralStrong buy
Neutral
score 0.00 · 18 signalling
4Buy
10Neutral
4Sell

No clear lean. 4 buy, 10 neutral and 4 sell across 18 signals. Stoch RSI sits in oversold territory. Trend strength is strong (ADX 25).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 2.48 · Signal 4.22 · Hist −1.74
Sell
ADX 14
Strong trend, +DI slightly ahead
ADX 25.07 · +DI 27.53 · −DI 24.17
Buy
Parabolic SAR 0.02, 0.2
Above price, 14.57 over the close
300.77
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion level with base
Conv 290.54 · Base 290.47 · A 273.21 · B 266.30
Neutral

Momentum

RSI 14
Mid-range, no extreme
49.19
Neutral
Stoch 14, 3
Low, %K just crossed over %D
%K 27.42 · %D 21.97
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 6.15 · %D 7.75
Neutral
Williams %R 14
Mid-range, still rising
−72.58
Neutral
CCI 14
Negative, above −100
−84.84
Neutral
MFI 14
Above midpoint, not overbought
63.94
Neutral
ROC 12
Price down 2.93% over 12 bars
−2.93%
Sell
AO 5, 35
Above zero, falling
4.46
Neutral
TRIX 18
Above zero
0.248
Buy
KST 10/15/20/30, 3
Below its signal line
KST 49.81 · Signal 54.77
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.23
Up 298.22 · Mid 290.44 · Low 282.66
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 298.54 · Mid 288.54 · Low 278.54
Neutral

Volume

VWAP 345-bar
Close 23.8% above VWAP
231.17
Buy
Force Index 1
Positive, buyers in control
23.3M
Buy
ATR
6.70
2.34% of close
A/D Line
103.1M
cumulative
OBV
83.9M
cumulative
Volume Profile
218.43 – 226.88
POC · bull 348.7M · bear 323.4M · 52 / 48
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

0.35%

Change in value over the past month.

3 month return

8.20%

Change in value over the last three months.

Max drawdown

16.43%

Largest fall from a peak to the low that followed.

Standard deviation

25.86%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.09

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.72

Annualised return against the maximum drawdown.

About

ABBV summary

Loading summary…

Questions

ABBV, answered

What are the key performance metrics for ABBV?

Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.

How does ABBV perform compared to its industry peers?

ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.

How often does ABBV distribute dividends?

ABBV typically distributes dividends on a quarterly basis, providing a steady income stream for investors.

Are there any risks associated with investing in ABBV?

Yes, risks include competition in the biopharmaceutical space, regulatory challenges, and the potential for patent expirations on key products.

What is the dividend yield of ABBV?

As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.

Can ABBV be used in a retirement account?

Yes, ABBV can be held in retirement accounts such as IRAs or 401(k)s, making it a suitable choice for long-term investment strategies.

What types of products does ABBV offer?

ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.

How does ABBV handle dividends?

Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.

What is the historical performance of ABBV?

Historically, ABBV has demonstrated strong performance, particularly driven by its flagship products in immunology and oncology.

How frequently is ABBV rebalanced?

ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.

News

ABBV in the news

Empower Your ABBV Trading Now

Elevate your trading strategy with OHLCX Markets’s sophisticated tools for ABBV. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Boost your investment success with us and explore the benefits of advanced trading now!

Get Advanced Analysis Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.